PRVA
Privia Health Group Inc
20.90$
+3.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.8% | +3.2% | +4.5% | +6.3% | -0.9% | +4.2% | +7.5% | +6.2% | +1.4% | +3.5% | +104,885.5% | |
| – | +0.4% | +3.9% | +7.1% | +9.5% | -2.2% | +6.2% | -0.4% | +10.0% | -6.2% | +6.0% | +106,032.8% | |
| – | +17.9% | -9.9% | +10.3% | +8.9% | +16.4% | -4.4% | -16.9% | +13.1% | +8.7% | -12.5% | +98,154.2% | |
| – | +17.9% | -9.9% | +10.3% | +8.9% | +16.4% | -4.4% | -16.9% | +13.1% | +8.7% | -12.5% | +98,154.2% | |
| – | -16.9% | +19.0% | +6.9% | +10.5% | -22.7% | +22.9% | +14.2% | +12.4% | -19.7% | +28.1% | +111,674.7% | |
| – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +2.3% | +0.5% | +0.0% | +0.0% | +1.5% | +0.0% | +21.6% | +0.0% | +21.8% | +0.0% | +102,734.0% | |
| – | +0.4% | -1.4% | -1.4% | -1.4% | +6.5% | -1.5% | +57.3% | -1.5% | +28.9% | -1.5% | +102,658.7% | |
| – | -2.2% | +4.1% | +6.2% | +11.4% | -6.4% | +4.8% | +13.7% | +9.1% | -1.7% | +5.8% | +106,194.2% | |
| – | -1.8% | +4.4% | +6.4% | +11.6% | -6.3% | +4.8% | +13.6% | +9.0% | -2.5% | +5.8% | +105,412.4% | |
| – | +88.7% | -53.0% | -7.4% | -2.6% | -1.0% | -6.5% | +4.9% | +2.4% | -14.2% | -3.9% | +97,727.2% | |
| – | +10.4% | -18.4% | +40.9% | -23.5% | +40.7% | -18.5% | +13.4% | +13.3% | -22.0% | +6,538.4% | -98.4% | |
| – | +3.1% | +2.7% | +3.2% | +3.3% | +3.3% | +3.8% | +3.6% | +3.8% | +4.0% | +2.1% | +103,786.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | +0.2% | +0.2% | +0.3% | +0.5% | +1.1% | +0.5% | +0.3% | +1.2% | +0.4% | +0.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.